Dr. Ross, an expert in virology, vaccines, immunology and microbiology, will focus on development of novel vaccine platforms for flu, HIV, COVID-19 and other infectious diseases, according to an April 28 news release.
“Ted is one of the preeminent vaccine researchers in the world,” Serpil Erzurum, MD, chief research and academic officer at Cleveland Clinic, said in the release. “His groundbreaking translational research will accelerate our efforts to develop critically needed new treatments and vaccines for pathogens and virus-induced cancers.”
Previously, Dr. Ross was the Georgia Research Alliance Eminent Scholar of Infectious Diseases and director of the Center for Vaccines and Immunology at the University of Georgia in Athens. He also previously served as director of vaccines and viral immunity at the Vaccine and Gene Therapy Institute of Florida in Port St. Lucie.
In his new role, Dr. Ross will be based at Cleveland Clinic’s Florida Research and Innovation Center, also in Port St. Lucie, according to the release.
Cleveland Clinic is an integrated international health system with more than 65,000 employees worldwide.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
